Clinical Trial Update: Testing of HIV Protease Inhibitors to Suppress Inflammation and Improve Cardio Pulmonary Hemodynamics in Subjects With Pulmonary Arterial Hypertension [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update evaluating whether HIV protease inhibitors can reduce inflammation and improve cardiopulmonary hemodynamics in individuals with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• HIV protease inhibitors

Snippet

Sponsor: The Third Xiangya Hospital of Central South University | Conditions: Pulmonary Arterial Hypertension | EARLY_Phase 1 | Status: UNKNOWN